Future postmortem studies that determine the central nervous system pathology (eg, TAR DNA-binding protein 43, tau, β-amyloid deposition) underlying the motor neuron deficits and the cognitive impairment may resolve the nature of this overlap with other neurodegenerative diseases. Here, MAPT is linked to neurodegenerative disease.